The diagnosis, treatment, and management of gynecologic malignancies benefit from both positron emission tomography/computed tomography (PET/CT) and MRI. PET/CT provides important information on the local extent of disease as well as diffuse metastatic involvement. MRI offers soft tissue delineation and loco-regional disease involvement. The combination of these two technologies is key in diagnosis, treatment planning, and evaluating treatment response in gynecological malignancies. This review aims to assess the performance of PET/MRI in gynecologic cancer patients and outlines the technical challenges and clinical advantages of PET/MR systems when specifically applied to gynecologic malignancies.
正电子发射断层扫描/计算机断层扫描（PET/CT）与磁共振成像（MRI）在妇科恶性肿瘤的诊断、治疗及管理中均具有重要价值。PET/CT能提供关于病灶局部范围及弥漫性转移的关键信息，而MRI则擅长软组织分辨与局部区域病变的评估。两种技术的结合对于妇科恶性肿瘤的诊断、治疗方案制定及疗效评估至关重要。本综述旨在评估PET/MRI在妇科癌症患者中的应用效果，并重点阐述PET/MR系统在妇科恶性肿瘤领域应用时面临的技术挑战与临床优势。
肿瘤(癌症)患者之家